Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 6929 Results

Ohio researchers develop ‘theranostic’ for acute lymphoblastic leukemia

Case Western Reserve University School of Medicine researchers have developed the first “theranostic” agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer diagnosed in approximately 5,000 new cases each year in the U.S. The Case research findings provide insight into pediatric oncology that specifically focuses on the development […]

March 19, 2012

BioOhio helps launch We Work For Health Ohio coalition

We Work for Health Ohio, a grassroots coalition formed to demonstrate the impact of Ohio’s growing biopharmaceutical industry its contributions to the state’s economy and the health of Ohioans, was announced today. BioOhio President and CEO Tony Dennis will be co-chairing the effort with Andrew Doehrel, president and CEO of the Ohio Chamber of Commerce. […]

March 15, 2012

Battelle expands global bioscience R&D presence

The world’s largest independent research and development organization is getting larger. This time, across the pond. Battelle has begun construction of an advanced research and development facility in the United Kingdom that will expand its global footprint and capacity to provide advanced science and technology solutions for the health care, agriculture, and food industries. The […]

March 12, 2012

News du jour: Medpace opens office in Lyon

This week Cincinnati CRO Medpace opened a new fully-staffed, clinical operations office in Lyon, France. This addition brings the total number of Medpace offices across Europe to eleven (insert Spinal Tap joke here, if you must). The office will be led by Patrick Winkler. More details and crêpes here.

March 8, 2012

Great Lakes NeuroTechnologies awarded patent for Parkinson’s assessment technology

BioOhio-member Great Lakes NeuroTechnologies received a patent covering advances to the company’s wireless patient-worn motion sensors that assess tremor, bradykinesia, rigidity, and dyskinesias associated with diseases like Parkinson’s and essential tremor. The Kinesia and Kinesia HomeView technology platform is FDA approved and has applications for both in-clinic and home-based patient care, as well as telemedicine.

March 8, 2012

Wright State biomed engineering students aim to improve prosthetics for injured veterans

A team of Wright State University student researchers is determined to make artificial limbs more comfortable and, consequently, more useful. The students are working on a new design they hope to someday test at the Dayton VA Medical Center, which has 500 hospital beds and provides a full range of health care to veterans. Tarun […]

March 6, 2012

Abbott Nutrition to expand manufacturing in Ohio

Abbott announced plans to build a nutrition manufacturing facility in Tipp City to produce two of the company’s fastest-growing adult brands, Ensure and Glucerna, for the North America market. Abbott will invest $270 million in the facility and will employ approximately 240 people. Groundbreaking is expected in April with the plant operational in late 2013. […]

March 4, 2012

Battelle’s biomedical business growth celebrated by BioOhio, Edison Centers

BioOhio is one of seven Ohio Edison Technology Centers providing a variety of product and process innovation and commercialization services to both established and early-stage technology-based businesses. Every year each Edison Center selects an organization in its industry segment to receive an Edison Award in recognition of significant commitment to growth. This year, BioOhio selected Battelle […]

March 3, 2012

Bioscience prominent in Higher Education Capital Funding recommendations

Wright State University’s Neuroscience Engineering Collaboration is just one of many biomedical- or life science-related projects listed in a recent proposal from the Higher Education Capital Funding Commission, a committee of seven university and community college leaders formed to advise Gov. Kasich on capital projects at public institutions. Anticipating the realities of an austere capital construction budget, […]

February 28, 2012

CTI manages expanded access program of recently FDA-approved drug

Cincinnati-based CTI Clinical Trial and Consulting Services has been involved in managing an Expanded Access Program for Voraxaze (glucarpidase), for which BTG International Inc. recently received FDA regulatory approval. The program provided emergency use of glucarpidase within 24 hours for patients with methotrexate toxicity and impaired renal function under a treatment protocol. CTI provided 24/7 […]

February 27, 2012